Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg
Description
In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention (7 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
Dr Philip Tong
Itch Across the Ages – Practical Guide to Assessment and Management
Dr Rupert Hinds
Abdominal Pain in Children – Practical Approach in GP
Prof Roger Chen
Practical Guide to Improving Control of T2D
A/Prof Debbie Rigby
Why Inhaler Device Design and Technique Matters
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
